Can scintimammography with 99(m)Tc-MIBI identify multifocal and multicentric primary breast cancer?
Nuclear Medicine Communications
1287 - 1293.
Scintimammography with Tc-99m-MIBI has been shown to be an effective adjunct to imaging of the breast with mammography. Uptake of Tc-99m-MIBI is particularly high in sites of non- calcified cancer and ductal carcinoma in situ (DCIS), and as a consequence it may be possible to use this method of imaging in identifying multifocal or multicentric disease. The aim of this study was to evaluate the efficacy of preoperative scintimammography in the detection of multifocal and multicentric breast cancer and compare these results with mammography. A retrospective review was performed of 353 women imaged with Tc-99m-MIBI as part of the clinical assessment of their suspected primary breast cancer. The results of the scintimammography and mammography were then compared with the final pathological diagnosis obtained after mastectomy in all patients. Histopathological assessments of breast tissue from mastectomy confirmed 40 women (12%) had multifocal (34) or multicentric (six) breast cancer. Scintimammography correctly identified 39 of these cancers and the multifocal or multicentric character of the cancer was identified in 22 (52%.) of these patients. Anatomical imaging performed in all 40 patients including 25 with mammography alone, mammography and ultrasound in 11 cases and ultrasound alone in four patients. Anatomical imaging identified cancer to be present in 28 patients (70%) and the combination of mammography and ultrasound identified correctly that the cancer was multifocal or multicentric in eight patients (22%). In this study scintimammography was able to identify more cases of multifocal and multicentric cancer than mammography and/or ultrasound. In patients where pre-operative identification of multicentric or multifocal disease can alter treatment scintimammography may be a useful investigative tool. ((C) 2001 Lippincott Williams & Wilkins)
|Title:||Can scintimammography with 99(m)Tc-MIBI identify multifocal and multicentric primary breast cancer?|
|Additional information:||WoS ID: 000172475200003 JDEC|
|Keywords:||As, assessment, ASSESSMENTS, Biopsy, Breast, BREAST CANCER, Breast tissue, BREAST-CANCER, cancer, cancers, Carcinoma, Carcinoma in Situ, CARCINOMA-IN-SITU, clinical, Clinical assessment, COMBINATION, Dec, detection, diagnosis, disease, EFFICACY, English, histopathological, IDENTIFICATION, imaging, in situ, IN-SITU, Lesions, Mammography, Management, mastectomy, May, MED, Patient, patients, Result, Review, Scintimammography, SITE, SITES, SITU, ST, Tc-99m-MIBI, Tissue, TOOL, treatment, TRIPLE ASSESSMENT, ultrasound, uptake, USA, Use, Williams, WOMEN|
|UCL classification:||UCL > School of Life and Medical Sciences > Faculty of Medical Sciences > Medicine (Division of)|
Archive Staff Only